Site icon

Section 8.1.2: Autism Spectrum Disorder

Wendell Nakamura

(Children 1st, n.d.)
LEARNING OBJECTIVES:
  1. Describe the etiology and risk factors that are associated with autism spectrum disorder (ASD).
  2. Describe the DSM-5-TR diagnostic criteria for ASD.
  3. Identify clinical presentation and common manifestations for people with ASD.
  4. Analyze the literature to identify how ASD impacts occupational performance of people from infants through adulthood.
  5. Describe the pathophysiology of ASD in terms of body functions and structures (including relevant neurotransmitters).
  6. Discuss common medical and pharmacological interventions in the management of ASD.
CASE STUDY:
Tommy is an Autistic 6 year old boy. Since starting kindergarten, Tommy has been having difficulty with aggression and behavioral outbursts. His teachers and family need help. He is admitted to the inpatient pediatric unit today so that the healthcare team can complete a detailed assessment and develop a comprehensive treatment plan to support Tommy as he begins school.

Read more about Tommy by following this link to his EHR.

Autism spectrum disorder (ASD) is “a neurological and developmental disorder that affects how people interact with others, communicate, learn, and behave” (National Institute of Mental Health Information Resource Center, n.d., §1). It is considered to be a lifelong and developmental condition because symptoms generally begin to appear around two years of age and persists throughout one’s lifetime. ASD also presents as a broad spectrum of characteristics, from mild to severe and not all people with ASD present with all characteristics. To view a short video that describes a parent’s perspective of ASD, follow this link. To view a short video of a simulation of the perspective of someone with ASD, follow this link.

The global prevalence of people diagnosed with autism spectrum disorder has been estimated to be highest in the Americas and Europe; lowest in the Western Pacific and Southeast Asia (Zeidan et al., 2022).

(Zeidan et al., 2022)

In many developing countries, prevalence rates appear to be lower because of poorer access to behavioral health services. The diagnostic criteria and tools to measure for ASD were developed with very Western notions of typical behavior. It is important to keep in mind cultural expectations and norms for social interactions must be considered. For example, imaginative play (e.g., make-believe or role-playing) is highly encouraged in Western cultures. In other cultures, play is more functional and literal play (i.e., using objects in the manner in which they are intended) is encouraged; imaginative play in not encouraged. In the use of language, there are some African cultures in which personal pronouns (e.g., I, you, he, she, we, they) are not used and instead, names are used). Additionally, cultural expectations on when a child begins to speak vary widely. In Western cultures, the expectation is that chillren begin speaking around 12 to 18 months of age. In some South Asian cultures, male infants are not expected to begin speaking until age three or four years. Finally, be aware that using eye contact or lack of eye contact is culturally driven; in many cultures, direct eye contact is discouraged, as it shows a sign of disrespect.

If we look at the prevalence rate in the U.S., we see that over time, the prevalence of individuals diagnosed with ASD has steadily increased. This is most likely due to increased awareness and more specific diagnostic criteria to identify children with ASD.

(Autism and Developmental Disabilities Monitoring Network, n.d.)

In the U.S., boys are 3.8 times more likely to be diagnosed with ASD than girls (Autism and Developmental Disabilities Monitoring Network, n.d.).

(Autsim and Developmental Disabilities Monitoring Network, n.d.)

Children from Asian/Pacific Islander and Hispanic families are also more likely to be diagnosed with ASD (Autism and Developmental Disabilities Monitoring Network, n.d.).

(Autism and Developmental Disabilities Monitoring Network, n.d.)

A number of comorbidities occur with autism spectrum disorder (Al-Betalgi, 2021; American Occupational Therapy Association, 2022; Kim & Lord, 2013; Sauer et al., 2022):



Causes of Autism Spectrum Disorder

Etiology/risk factors for autism spectrum disorder falls into two broad categories: genetic and environmental (Betancur & Coleman, 2013; Lydall et al., 2013; Sauer et al., 2022).

Genetic factors:

Environmental factors:



Clinical Presentation of Autism Spectrum Disorder

The current framework for understanding and diagnosing autism spectrum disorder can be found in the Diagnostic and Statistics Manual of Mental Disorders, Text Revision (DSM-5-TR). People may be diagnosed with ASD if they meet BOTH of the following criteria (National Center on Birth Defects and Developmental Disabilities, n.d.b):


Examples of deficits in social communication and social interaction may include (National Institutes of Mental Health Information Center, n.d.):

Examples of restrictive or repetitive behaviors include (National Institute of Mental Health Information Center, n.d.):

To view a short video that compares typical development versus ASD, follow this link.

FOCUS ON CLINICAL APPLICATION:
  1. You will work in small groups of three to four students for this activity.
  2. Select one of the following articles to review that describes limitations in occupational performance and intervention recommendations for individuals with autism spectrum disorder.
  • Baker, A., Tomchek, S. D., Little, L. M., Wallisch, A., & Dean, E. (2023). Systematic review brief – Interventions to support participation in basic and instrumental activities of daily living for autistic children and adolescents (2013-2021). American Journal of Occupational Therapy, 77(Suppl. 1), Article 7710393140. https://doi.org/10.5014/ajot.2023.77S10014
  • Holmes, L. G., Goebel, R. J., Hollingue, C., Zhu, S., Zhang, H., Shan, W., Wang, S., Caplan, R., Sanchez, A., Wharmby, P., Chiang, M., Person, M., & Rothman, E. F. (2023). Reductions in depression and anxiety among autistic adults participating in an intervention to promote healthy relationships. American Journal of Occupational Therapy, 77(2), Article 7702185070. https://doi.org/10.5014/ajot.2023.050108
  • Kersten, M., Coxon, K., Lee, H., & Wilson, N. J. (2020). Independent community mobility and driving experiences of adults on the autism spectrum: A scoping review. American Journal of Occupational Therapy, 74(5), Article 7405205140. https://doi.org/10.5014/ajot.2020.040311
  • Koceski, A., & Trajkovski, V. (2021). Functional status of people with autism spectrum disorder. Journal for ReAttachment Therapy and Developmental Diversities, 4(1), 17-27. https://doi.org/10.26407/2021.jrtdd.1.44 NOTE: Use this link (https://jrtdd.com/index.php/journal/article/view/42), as the DOI provided in the article is incorrect.
  • Little, L. M., Cohen, S. R., Tomchek, S. D., Baker, A., Wallisch, A., & Dean, E. (2023). Systematic review brief – Clinic-based interventions to support social participation for autistic children and adolescents (2013-2021). American Journal of Occupational Therapy, 77(Suppl. 1), Article 7710393190. https://doi.org/10.5014/ajot.2023.77S10019
  • Miller Kuhanek, H. M., Madonna, S., Novak, A., & Pearson, E. (2015). Effectiveness of interventions for children with autism spectrum disorder and their parents: A systematic review of family outcomes. American Journal of Occupational Therapy, 69(5), Article 6905180040. https://doi.org/10.5014/ajot.2015.017855
  • Each group will report out their findings to the class.


  • Body Functions & Body Structures of Autism Spectrum Disorder

    There is no characteristic brain structure for autism, meaning that no single pattern of structural changes occurs in every individual with autism. There is great variety in the brain structures of people with autism. There are, however, emerging patterns in brain structures between people with and without ASD that are becoming evident. In particular, brain tissue in the cerebellum, parts of the limbic system, and the frontal cortex demonstrate some differences in size, number, and density.

    (Boglio, 2020)

    Cerebellum

    You will recall from Section 8.1 that the cerebellum arises from the rhombencephalon (hindbrain). The cerebellum’s function is to regulate and refine balance and posture, muscle tone, motor control, language processing, emotional regulation, oculomotor function for visual-spatial relations, and executive functioning (Jimshileishvili & Dididze, 2023). People with ASD generally have decreased size, number, and density of Purkinje cells in the cerebellum. Purkinje cells are large, flat neurons with profuse dendritic branching that secrete the inhibitory neurotransmitter, gamma aminobutyric acid (GABA). These Purkinje cells inhibit specific motor plans within the motor cortex and regulate and refine movement patterns, thereby assisting with error correction. People with ASD have decreased GABA secretion, which results in difficulty with language processing, visual spatial relations, emotional regulation, and executive functioning (Askham, 2020; Bauman & Kemper, 2013; Donovan & Basson, 2017; Roth & Rowell, 2020; Stigler & McDougle, 2013).


    Limbic System

    You will recall from Section 8.1 that the limbic system is responsible for lower order emotional processing, especially those emotions related to survival (e.g., anger, fear, joy, sadness, disgust, and surprise) and whose facial expressions are generally recognized across cultures (Simic et al., 2021). We focused our earlier discussion of the limbic system on three primary structures: the hippocampus, amygdala, and cingulate gyrus. Alterations in the structures of the limbic system are implicated in characteristic behaviors associated with autism spectrum disorder (Askham, 2020; Morgan et al., 2013; Roth & Rowell, 2020; Stigler & Mcdougle, 2013; Uppal & Hof, 2013; Wright, 2020a, 2020b)

    (Betts et al., 2022, Fig. 15.12)

    The hippocampus is involved in the formation and storage of the emotional components of associative learning (prediction of behavior and consequences), declarative learning (encoding, storing, and retrieving facts), and memory. In people with ASD, the hippocampus is often enlarged compared to typical people and is responsible for hypervigilance and heightened emotions in people with ASD.

    The amygdala is involved in emotional regulation and initiates the sympathetic nervous system (fight-flight response). People with ASD often have an enlarged amygdala, resulting in difficulties with emotional regulation, decreased attention to faces of others (particularly the eye region). This second feature translates to the inability of many people with ASD to read the facial cues of others.

    The cingulate gyrus is involved in the integration of emotions, sustaining and shifting attention, and the suppression of a response to non-relevant stimuli. A decreased density of nerons in and reduced volume of the cingulate gyrus in people with ASD is associated with poorer emotional regulation, an inability to shift or sustain attention, and a hypervigilance to stimuli.


    Frontal Cortex

    You will recall that Broca’s area is usually located in the inferior frontal gyrus of the frontal cortex of the left hemisphere. It is historically associated with the motor aspect of speech production, semantics, phonology, gesture production, sentence grammar and fluidity, and interpretation of the actions of others (Stinnett et al., 2023). A lesion in Broca’s area results in expressive (non-fluid) aphasia (refer back to Section 8.1). You will further recall that Wernicke’s area is located in the superior temporal gyrus of the temporal lobe. Wernicke’s area is associated with speech comprehension (Javed et al., 2023) and lesions in Wernicke’s area typically results in receptive aphasia.

    In people with ASD, the size and density of neurons in Broca’s area impacted and there are fewer connections between Broca’s area and Wernicke’s area. As a result, people with ASD tend to have greater challenges with verbal and written expression, reciprocal communication, and understanding and using metaphors (Geggel, 2013; Roth & Rowell, 2020; Uppal & Hof, 2013).

    (Wright, 2020a, Fig. 8.2)

    Neurotransmitters

    Imbalances in a number of neurotransmitters is also implicated in people with ASD (Blatt, 2013; Marotta et al., 2020; Roth & Rowell, 2020).



    Medical Management & Pharmacology

    When considering the management of autism spectrum disorder, it is important to keep in mind two very important things. First, people with ASD present in a wide variety of ways, from severe (non-communicative, highly restrictive behaviors, and requiring very substantial support to function) to very mild (advanced communication skills, non-restrictive behavior, and requires little support to function). As with all occupational therapy interventions, approaches to management of symptoms should always be highly tailored to the individual’s occupational performance needs. Secondly, the approach to intervention should be guided by the lens that is most appropriate to the individual’s context. This can range from a biomedical approach in which ASD is seen as a medical condition that needs to be “fixed” to a neurodivergent perspective in which the individual’s social environment needs to be modified to maximize functioning. To that end, there are several means available to people with ASD (National Center on Birth Defects and Developmental Disabilities, n.d.d; Roth & Rowell, 2020).



    Summary

    Autism spectrum disorder affects people from all parts of the world, regardless of race, income, and cultural background. However, it disproportionally impacts those with poorer maternal healthcare, lower education, and greater exposure to environmental toxins. ASD exists with a number of comorbidities, including intellectual disabilities and psychiatric disorders. People with ASD present over a wide variety of characteristics and the diagnosis of ASD may involve cultural biases. ASD can significantly impact occupational performance and social development. Despite the wide range of clinical presentations, some trends in neuroanatomical differences are becoming evident in the literature. Size and neuronal density of parts of the cerebellum, limbic system, and frontal cortex suggest patterns in the development of ASD. Additionally, various imbalances in neurotransmitters can also impact clinical presentation. Pharmacological interventions are an attempt at correcting neurotransmitter imbalances and educational, behavioral, and developmental approaches are some strategies to maximize functioning in people with ASD.








    REFERENCES

    Al-Betalgi, M. (2021). Autism medical comorbidities. World Journal of Clinical Pediatrics, 10(3), 15-28. https://doi.org/10.5409/wjcp.v10.i3.15


    American Occupational Therapy Association. (2022). Position statement – Autism spectrum disorders across the life course and occupational therapy services. American Journal of Occupational Therapy, 76(Suppl. S3), Article 7613410210. https://doi.org/10.5014/ajot.2022.76S3002


    Askham, A. V. (2020, October 15). Brain structure changes in autism, explained. Spectrum. https://www.spectrumnews.org/news/brain-structure-changes-in-autism-explained/


    Autism and Developmental Disabilities Monitoring Network. (n.d.). Autism data visualization tool. Centers for Disease Control and Prevention. Retrieved March 7, 2024 from https://www.cdc.gov/ncbddd/autism/data/#accessible


    Bauman, M. L., & Kemper, T. L. (2013). The cerebellum in autism spectrum disorder. In J. D. Buxbaum & P. R. Hof, The neuroscience of autism spectrum disorders (pp. 289-295). Academic Press.


    Betancur, C., & Coleman, M. (2013). Etiological heterogeneity in autism spectrum disorders: Role of rare variants. In J. D. Buxbaum & P. R. Huf (Eds.), The neuroscience of autism spectrum disorders (pp. 113-144). Academic Press.


    Betts, G. J., Young, K. A., Wise, J. A., Johnson, E., Poe, B., Kruse, D. H., Korol, O., Johnson, J. E., Womble, M., & DeSaix, P. (2022). Anatomy and physiology (2nd ed.). OpenStax. https://openstax.org/details/books/anatomy-and-physiology-2e


    Blatt, G. J. (2013). Inhibitory and excitatory systems in autism spectrum disorders. In J. D. Buxbaum & P. R. Hof, The neuroscience of autism spectrum disorders (pp. 335-346). Academic Press.


    Boglio, L. (2020, October 15). Structural brain differences explainer [Illustration]. The transmitter. https://www.thetransmitter.org/spectrum/brain-structure-changes-in-autism-explained/?fspec=1


    Children 1st. (n.d.). Challenging or distressed behavior [Photograph]. Retrieved on August 16, 2024 from https://www.children1st.org.uk/help-for-families/parentline-scotland/guidance-advice/articles/challenging-or-distressed-behaviour/


    Donovan, A. P. A., & Basson, M. A. (2020). The neuroanatomy of autism – A developmental perspective. Journal of Anatomy, 230(1), 4-15. https://doi.org/10.1111/joa.12542


    Geggel, L. (2013, November 12). Language areas of the brain activate differently in autism. Spectrum. https://www.spectrumnews.org/news/language-areas-of-the-brain-activate-differently-in-autism/


    Javed, K., Reddy, V., Das, J. M., & Wroten, M. (2023, July 24). Neuroanatomy, Wernicke area [eBook]. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK533001/


    Jimsheleishvili, S., & Dididze, M. (2023, July 24). Neuroanatomy, cerebellum [eBook]. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK538167/


    Kim, S. H., & Lord, C. (2013). The behavioral manifestations of autism spectrum disorder. In J. D. Buxbaum & P. R. Hof, The neuroscience of autism spectrum disorders (pp. 25-37). Academic Press.


    LeClerc, S., & Easley, D. (2015). Pharmacological therapies for autism spectrum disorder: A review. Pharmacy and Therapeutics, 40(6), 389-397. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450669/pdf/ptj4006389.pdf


    Lydall, K., Schmidt, R. J., & Hertz-Picciotto, I. (2013). The environment in autism spectrum disorders. In J. D. Buxbaum & P. R. Hof, The neuroscience of autism spectrum disorders (pp. 203-214). Academic Press.


    Marotta, R., Risoleo, M. C., Messina, G., Parisi, L., Carotenuto, M., Vetri, L., & Rocella, M. (2017). The neurochemistry of autism. Brain Sciences, 10(3). Article 163. https://doi.org/10.3390/brainsci10030163


    Morgan, J. T., Nordahl, C. W., & Schumann, C. M. (2013). The amygdala in autism spectrum disorders. In J. D. Buxbaum & P. R. Hof, The neuroscience of autism spectrum disorders (pp. 297-312). Academic Press.


    Mughal, S., Faizy, R. M., & Saadabadi, A. (2022, July 19). Autism spectrum disorder [eBook]. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK525976/


    National Center on Birth Defects and Developmental Disabilities. (n.d.a). Autism spectrum disorder (ASD). Centers for Disease Control and Prevention. Retrieved on March 7, 2024 from https://www.cdc.gov/ncbddd/autism/index.html


    National Center on Birth Defects and Developmental Disabilities. (n.d.b). Autism spectrum disorder – Diagnostic criteria. Centers for Disease Control and Prevention. Retrieved on March 7, 2024 from https://www.cdc.gov/ncbddd/autism/hcp-dsm.html


    National Center on Birth Defects and Developmental Disabilities. (n.d.c). Autism spectrum disorder – What is autism spectrum disorder? Centers for Disease Control and Prevention. Retrieved on March 7, 2024 from https://www.cdc.gov/ncbddd/autism/facts.html


    National Center on Birth Defects and Developmental Disabilities. (n.d.d). Treatment and intervention services for autism spectrum disorder. Centers for Disease Control and Prevention. Retrieved on March 7, 2024 from https://www.cdc.gov/ncbddd/autism/treatment.html#Complementary-Alternative


    National Institute of Mental Health Information Resource Center. (n.d.). Autism spectrum disorder – What is ASD? National Institute of Mental Health. Retrieved on March 7, 2024 from https://www.nimh.nih.gov/health/topics/autism-spectrum-disorders-asd


    Nilsson, I., & Townsend, E. (2010). Occupational justice – Bridging theory and practice. Scandinavian Journal of Occupational Therapy, 17(1), 57-63. https://doi.org/10.3109/11038120903287182


    Roth, I., & Rowell, N. (2020, February 4). Understanding autism. Open University. https://www.open.edu/openlearn/science-maths-technology/understanding-autism/


    Sauer, A. K., Stanton, J. E., Hans, S., & Grabrucker, Am. M. (2021). Autism spectrum disorders: Etiology and pathology. In A. M. Grabrucker (Ed.), Autism spectrum disorders (pp. 1-16). https://doi.org/10.36255/exonpublications.autismspectrumdisorders.2021.etiology


    Simic, G., Tkalcic, M., Vukic, V., Mulc, D., Spanic, E., Sagud, M., Olucha-Bordonau, F. E., Vuksic, M., & Hof, P. R. (2021). Understanding emotions: Origins and roles of the amygdala. Biomolecules, 11(6), 823. https://doi.org/10.3390/biom11060823


    Stigler, K. A., & McDougle, C. J. (2013). Structural and functional MRI studies of autism spectrum disorder. In In J. D. Buxbaum & P. R. Hof, The neuroscience of autism spectrum disorders (pp. 251-266). Academic Press.


    Stinnett, T. J., Reddy, V., & Zabel, M. K. (2023, August 8). Neuroanatomy, Broca’s area [eBook]. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK526096/


    Uppal, N., & Hof, P. R. (2013). Discrete cortical neuropathy in autism spectrum disorder. In J. D. Buxbaum & P. R. Hof, The neuroscience of autism spectrum disorders (pp. 313-325). Academic Press.


    Wright, A. (2020a, October 10). Higher cortical functions: Language. In McGovern Medical School at UTHealth. Neuroscience Online. https://nba.uth.tmc.edu/neuroscience/s4/chapter08.html


    Wright, A. (2020b, October 10). Limbic system: Amygdala. In McGivern Medical School at UTHealth. Neuroscience Online. https://nba.uth.tmc.edu/neuroscience/s4/chapter06.html


    Wright, A. (2020c, October 10). Limbic system: Hippocampus. In McGovern Medical School at UTHealth. Neuroscience Online. https://nba.uth.tmc.edu/neuroscience/s4/chapter05.html


    Zeidan, J., Fombonne, E., Scorah, J., Ibrahim, A., Durkin, M. S., Saxsena, S., Yusuf, A., Shih, A., & Elsabbagh, M. (2022). Global prevalence of autism: A systematic review update. Autism Research, 15(5), 778-790. https://doi.org/10.1002/aur.2696

    Exit mobile version
    Skip to toolbar